"With the extensive experience of our late phase services group, we have long understood the need for technology solutions focused on the specific needs of late phase and patient reported outcomes studies," said Maria Harrison, vice president, Late Phase Services, PRA. "We are delighted with the success we have achieved over the last year integrating OutcomeLogix with our innovative late phase and registry study models across sponsor projects. We look forward to our mutual continued success."
"We are pleased with the success that PRA International has achieved with OutcomeLogix to date and look forward to broadening our relationship," said Scott Dixon, vice president, OutcomeLogix Group, Phase Forward. "We value our relationship with PRA and are committed to working together to deliver best-of-breed solutions to the marketplace."
PRA's Late Phase Services group supports global and regional Post-approval studies. In the past three years, PRA has conducted over 160 late phase studies with nearly 18,000 sites and more than 187,000 patients in 42 countries.
((Comments on this story may be sent to health@closeupmedia.com))

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index